Titre : Récepteur de la sérotonine de type 5-HT1A

Récepteur de la sérotonine de type 5-HT1A : Questions médicales fréquentes

Termes MeSH sélectionnés :

Platelet Count
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Récepteur de la sérotonine de type 5-HT1A : Questions médicales les plus fréquentes", "headline": "Récepteur de la sérotonine de type 5-HT1A : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Récepteur de la sérotonine de type 5-HT1A : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-30", "dateModified": "2025-04-26", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Récepteur de la sérotonine de type 5-HT1A" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Récepteurs de la sérotonine de type 5-HT1", "url": "https://questionsmedicales.fr/mesh/D044263", "about": { "@type": "MedicalCondition", "name": "Récepteurs de la sérotonine de type 5-HT1", "code": { "@type": "MedicalCode", "code": "D044263", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.750.720.850.100" } } }, "about": { "@type": "MedicalCondition", "name": "Récepteur de la sérotonine de type 5-HT1A", "alternateName": "Receptor, Serotonin, 5-HT1A", "code": { "@type": "MedicalCode", "code": "D044282", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Evgeni Ponimaskin", "url": "https://questionsmedicales.fr/author/Evgeni%20Ponimaskin", "affiliation": { "@type": "Organization", "name": "Cellular Neurophysiology, Center of Physiology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany." } }, { "@type": "Person", "name": "Adrian Newman-Tancredi", "url": "https://questionsmedicales.fr/author/Adrian%20Newman-Tancredi", "affiliation": { "@type": "Organization", "name": "Neurolixis Inc., 251 Little Falls Drive Wilmington, 19808 Delaware, United States." } }, { "@type": "Person", "name": "Monika Bijata", "url": "https://questionsmedicales.fr/author/Monika%20Bijata", "affiliation": { "@type": "Organization", "name": "Nencki Institute of Experimental Biology, Polish Academy of Sciences, Pasteura 3, 02-093 Warsaw, Poland." } }, { "@type": "Person", "name": "Jakub Wlodarczyk", "url": "https://questionsmedicales.fr/author/Jakub%20Wlodarczyk", "affiliation": { "@type": "Organization", "name": "Nencki Institute of Experimental Biology, Polish Academy of Sciences, Pasteura 3, 02-093 Warsaw, Poland." } }, { "@type": "Person", "name": "Andre Zeug", "url": "https://questionsmedicales.fr/author/Andre%20Zeug", "affiliation": { "@type": "Organization", "name": "Cellular Neurophysiology, Hannover Medical School, Carl-Neuberg Str. 1, 30625, Hannover, Germany." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Platelet counts affect the association between hyperhomocysteinemia and pregnancy complications.", "datePublished": "2023-06-02", "url": "https://questionsmedicales.fr/article/37268909", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12889-023-16027-6" } }, { "@type": "ScholarlyArticle", "name": "Platelet count and plateletcrit: Potential haematological biomarkers for livedoid vasculopathy?", "datePublished": "2022-05-30", "url": "https://questionsmedicales.fr/article/35635484", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/ajd.13884" } }, { "@type": "ScholarlyArticle", "name": "Prognostic significance of mean platelet volume to platelet count ratio in pediatric patients with acute kidney injury.", "datePublished": "2024-07-11", "url": "https://questionsmedicales.fr/article/39024604", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.24953/turkjpediatr.2024.4514" } }, { "@type": "ScholarlyArticle", "name": "The safety and performance of the Spectra Optia apheresis system platelet depletion protocol in patients with elevated platelet counts.", "datePublished": "2022-09-14", "url": "https://questionsmedicales.fr/article/36102144", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/jca.22009" } }, { "@type": "ScholarlyArticle", "name": "Preeclampsia has an association with both platelet count and mean platelet volume: A systematic review and meta-analysis.", "datePublished": "2022-09-14", "url": "https://questionsmedicales.fr/article/36103491", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0274398" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines membranaires", "item": "https://questionsmedicales.fr/mesh/D008565" }, { "@type": "ListItem", "position": 5, "name": "Récepteurs de surface cellulaire", "item": "https://questionsmedicales.fr/mesh/D011956" }, { "@type": "ListItem", "position": 6, "name": "Récepteurs aux neuromédiateurs", "item": "https://questionsmedicales.fr/mesh/D017981" }, { "@type": "ListItem", "position": 7, "name": "Récepteurs sérotoninergiques", "item": "https://questionsmedicales.fr/mesh/D011985" }, { "@type": "ListItem", "position": 8, "name": "Récepteurs de la sérotonine de type 5-HT1", "item": "https://questionsmedicales.fr/mesh/D044263" }, { "@type": "ListItem", "position": 9, "name": "Récepteur de la sérotonine de type 5-HT1A", "item": "https://questionsmedicales.fr/mesh/D044282" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Récepteur de la sérotonine de type 5-HT1A - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Récepteur de la sérotonine de type 5-HT1A", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-10", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Récepteur de la sérotonine de type 5-HT1A", "description": "Comment diagnostiquer un dysfonctionnement du récepteur 5-HT1A ?\nQuels tests sont utilisés pour évaluer l'activité des récepteurs 5-HT1A ?\nLes antécédents familiaux influencent-ils le diagnostic ?\nQuels symptômes peuvent indiquer un problème avec 5-HT1A ?\nLes tests génétiques sont-ils utiles pour le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D044282?mesh_terms=Platelet+Count&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Récepteur de la sérotonine de type 5-HT1A", "description": "Quels symptômes sont associés à une dysfonction 5-HT1A ?\nLa dysfonction 5-HT1A peut-elle causer des troubles cognitifs ?\nY a-t-il des symptômes physiques liés à 5-HT1A ?\nLes changements d'humeur sont-ils fréquents ?\nComment la dysfonction 5-HT1A affecte-t-elle le sommeil ?", "url": "https://questionsmedicales.fr/mesh/D044282?mesh_terms=Platelet+Count&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Récepteur de la sérotonine de type 5-HT1A", "description": "Comment prévenir les troubles liés à 5-HT1A ?\nL'éducation sur la santé mentale est-elle importante ?\nLes groupes de soutien sont-ils bénéfiques ?\nLa méditation aide-t-elle à prévenir les troubles ?\nLes bilans de santé réguliers sont-ils utiles ?", "url": "https://questionsmedicales.fr/mesh/D044282?mesh_terms=Platelet+Count&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Récepteur de la sérotonine de type 5-HT1A", "description": "Quels traitements ciblent le récepteur 5-HT1A ?\nLa thérapie comportementale est-elle efficace ?\nLes médicaments naturels influencent-ils 5-HT1A ?\nLes changements de mode de vie aident-ils ?\nLes traitements sont-ils personnalisés ?", "url": "https://questionsmedicales.fr/mesh/D044282?mesh_terms=Platelet+Count&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Récepteur de la sérotonine de type 5-HT1A", "description": "Quelles complications peuvent survenir avec 5-HT1A ?\nLa dysfonction 5-HT1A peut-elle entraîner des dépendances ?\nY a-t-il des risques de troubles neurologiques ?\nLes complications cardiovasculaires sont-elles possibles ?\nComment les complications affectent-elles la qualité de vie ?", "url": "https://questionsmedicales.fr/mesh/D044282?mesh_terms=Platelet+Count&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Récepteur de la sérotonine de type 5-HT1A", "description": "Quels facteurs de risque sont associés à 5-HT1A ?\nLe sexe influence-t-il le risque de dysfonction 5-HT1A ?\nL'âge est-il un facteur de risque ?\nLes traumatismes passés augmentent-ils le risque ?\nLe mode de vie influence-t-il le risque ?", "url": "https://questionsmedicales.fr/mesh/D044282?mesh_terms=Platelet+Count&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer un dysfonctionnement du récepteur 5-HT1A ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des évaluations cliniques et des tests neurochimiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'activité des récepteurs 5-HT1A ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des techniques d'imagerie cérébrale et des tests de liaison de ligands sont utilisés." } }, { "@type": "Question", "name": "Les antécédents familiaux influencent-ils le diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de troubles psychiatriques peuvent indiquer un risque accru." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un problème avec 5-HT1A ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme l'anxiété, la dépression et des troubles de l'humeur peuvent survenir." } }, { "@type": "Question", "name": "Les tests génétiques sont-ils utiles pour le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent aider à identifier des variations génétiques liées aux récepteurs de la sérotonine." } }, { "@type": "Question", "name": "Quels symptômes sont associés à une dysfonction 5-HT1A ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Anxiété, dépression, troubles de l'humeur et problèmes de sommeil sont fréquents." } }, { "@type": "Question", "name": "La dysfonction 5-HT1A peut-elle causer des troubles cognitifs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut entraîner des troubles de la mémoire et de la concentration." } }, { "@type": "Question", "name": "Y a-t-il des symptômes physiques liés à 5-HT1A ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme des douleurs chroniques et des troubles gastro-intestinaux peuvent apparaître." } }, { "@type": "Question", "name": "Les changements d'humeur sont-ils fréquents ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des fluctuations d'humeur peuvent être un signe de dysfonctionnement du récepteur." } }, { "@type": "Question", "name": "Comment la dysfonction 5-HT1A affecte-t-elle le sommeil ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut provoquer des insomnies ou des troubles du sommeil, affectant la qualité de vie." } }, { "@type": "Question", "name": "Comment prévenir les troubles liés à 5-HT1A ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir un mode de vie sain et gérer le stress peut aider à prévenir les troubles." } }, { "@type": "Question", "name": "L'éducation sur la santé mentale est-elle importante ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut sensibiliser aux symptômes et encourager une intervention précoce." } }, { "@type": "Question", "name": "Les groupes de soutien sont-ils bénéfiques ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils offrent un soutien émotionnel et des stratégies de gestion des symptômes." } }, { "@type": "Question", "name": "La méditation aide-t-elle à prévenir les troubles ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la méditation peut réduire l'anxiété et améliorer le bien-être général." } }, { "@type": "Question", "name": "Les bilans de santé réguliers sont-ils utiles ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils permettent de détecter précocement des signes de dysfonctionnement." } }, { "@type": "Question", "name": "Quels traitements ciblent le récepteur 5-HT1A ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les antidépresseurs et les anxiolytiques agissent souvent sur ce récepteur." } }, { "@type": "Question", "name": "La thérapie comportementale est-elle efficace ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut aider à gérer les symptômes liés à la dysfonction du récepteur 5-HT1A." } }, { "@type": "Question", "name": "Les médicaments naturels influencent-ils 5-HT1A ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Certains extraits de plantes, comme le millepertuis, peuvent moduler ce récepteur." } }, { "@type": "Question", "name": "Les changements de mode de vie aident-ils ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation équilibrée et l'exercice peuvent améliorer la fonction du récepteur." } }, { "@type": "Question", "name": "Les traitements sont-ils personnalisés ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements peuvent être adaptés en fonction des symptômes et des antécédents." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec 5-HT1A ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles de l'humeur sévères et des comportements suicidaires peuvent survenir." } }, { "@type": "Question", "name": "La dysfonction 5-HT1A peut-elle entraîner des dépendances ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut augmenter le risque de dépendance à certaines substances." } }, { "@type": "Question", "name": "Y a-t-il des risques de troubles neurologiques ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles neurologiques comme la dépression chronique peuvent se développer." } }, { "@type": "Question", "name": "Les complications cardiovasculaires sont-elles possibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique lié à la dysfonction peut affecter la santé cardiovasculaire." } }, { "@type": "Question", "name": "Comment les complications affectent-elles la qualité de vie ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent réduire significativement la qualité de vie et le fonctionnement quotidien." } }, { "@type": "Question", "name": "Quels facteurs de risque sont associés à 5-HT1A ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents familiaux de troubles mentaux et le stress chronique sont des facteurs clés." } }, { "@type": "Question", "name": "Le sexe influence-t-il le risque de dysfonction 5-HT1A ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des études montrent que les femmes peuvent être plus susceptibles aux troubles." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque de dysfonction augmente souvent avec l'âge, surtout après 40 ans." } }, { "@type": "Question", "name": "Les traumatismes passés augmentent-ils le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traumatismes psychologiques peuvent accroître le risque de troubles liés à 5-HT1A." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter le risque." } } ] } ] }

Sources (8231 au total)

Platelet counts affect the association between hyperhomocysteinemia and pregnancy complications.

The joint effect of platelet and other modifiers on the risk of pregnancy complications is unknown. This study investigated whether platelet count (PC) and total homocysteine (tHcy) level have a syner... Total 11,553 consecutive pregnant women who received whole blood cell and biochemical tests at the time of admission for labor in Changzhou Maternal and Child Health Care Hospital were analyzed. The p... The prevalence of GDM, ICP, PE, and PIH was 8.4%, 6.2%, 3.4%, and 2.1%, respectively. The highest rate of ICP (28.6%) was observed in women with high tHcy (> 15 μmol/L) and low PC (quartile 1); and th... Among Chinese pregnant women, one subgroup (high tHcy and low PC) has the highest risk of ICP and another (high tHcy and high PC) has the lowest risk of GDM; tHcy and platelet could be used as indicat...

Platelet count and plateletcrit: Potential haematological biomarkers for livedoid vasculopathy?

The pathogenesis of livedoid vasculopathy (LV) remains unknown. Although platelet activation occurs in LV, little research has been conducted on LV platelet morphology parameters. The purpose of this ... Twenty-seven LV patients and 21 cutaneous small vessel vasculitis (CSVV) patients, all at the active stage, were included. Platelet parameters in active- and stable-stage LV and CSVV patients were com... LV patients' mean age was 25.48 years (range: 9-62 years), and 81.48% (22/27) were women and 18.52% (5/27) were men. The platelet counts and plateletcrit (PCT) levels were significantly elevated in LV... Altered platelet morphology was detected in LV patients. Platelet count and PCT might be haematological biomarkers for early prediction of LV activity and relapses and for differential identification ...

Prognostic significance of mean platelet volume to platelet count ratio in pediatric patients with acute kidney injury.

Mean platelet volume (MPV), which is regarded as a marker of thrombocyte function and activation, is related to increased morbidity and mortality. In critically ill patients, the ratio of MPV to plate... In this retrospective study, patients hospitalized in the pediatric intensive care unit (PICU) between March 2020 and June 2022 were evaluated. Patients between 1 month and 18 years of age with AKI we... Sixty-three children with AKI were included in the study. The total mortality rate was 34.9% (n=22). MPR ratios were significantly higher in the non-survivors at admission (p=0.042) and at the 72nd ho... MPR is an inexpensive and practical marker that may predict the outcome of children with AKI....

The safety and performance of the Spectra Optia apheresis system platelet depletion protocol in patients with elevated platelet counts.

Thrombocytosis is a presenting and progressive clinical feature found in multiple disease states. It is characterized by high platelet (PLT) counts (>450 × 10... This report details the results from 2 clinical studies, one conducted in the European Union (EU) and one in the People's Republic of China, assessing the PLTD procedure on the Spectra Optia Apheresis... Data were collected from 56 participants completing 64 PLTD procedures. The mean percent change in PLT count and collection efficiency (CE1) was 55.1% and 68.5%, respectively. In the EU study, 6 parti... The data collected within these studies indicate that the PLTD procedure is well tolerated and effective at reducing circulating PLTs in patients suffering from thrombocytosis as evaluated by a percen...

Preeclampsia has an association with both platelet count and mean platelet volume: A systematic review and meta-analysis.

Preeclampsia (PE) is a pregnancy-specific disorder characterized by endothelial dysfunction, and activation of the coagulation system. Alteration of PLT parameters is the common hematological abnormal... Relevant articles which were published in the English language from January 10, 2011, to January 10, 2021, were systematically searched through PubMed, Web of Science, and African journals online. In ... A total of 25 articles were included in this systematic review and meta-analysis. Of which, 23 studies were used in each PC and MPV analysis. The overall pooled WMD of PC and MPV between PE and NT gro... This systematic review and meta-analysis indicated that there is a significant decrease in PC and a significant increase in MPV during PE development among pregnant women. As a result, a change in the...

Comparison of platelet count results on the Sysmex XN between citrate or MgSO

The aim of this study performed on Sysmex XN is to compare platelet values on citrate and MgSO... Sixty patients with K2EDTA-induced platelet clusters were re-sampled with K2EDTA, citrate and TBX. Platelet results were then compared, and smears were analysed for clumping. Platelet results from 120... Out of the 60 patients with K2EDTA-induced platelet clusters, none showed platelet clusters with MgSO... In patients with K2EDTA-induced platelet clusters, MgSO...

Mean platelet volume/platelet count ratio in combination with tumor markers in colorectal cancer: a retrospective clinical study.

Mean platelet volume (MPV) is a marker of platelet activation, which is usually negatively correlated with platelet count (PC). The ratio of MPV to PC (MPV/PC) has an essential role in the diagnosis o... 200 patients with CRC and 317 patients with colorectal benign polypus pathologically diagnosed during 2019/01/04 to 2022/06/30 were included. Hematological and pathological parameters of the above pat... The MPV/PC in CRC group was significantly lower than the control group (P < 0.0001). Among the three tumor markers, higher CA125 was correlated with distant metastasis and lower differentiation (P < 0... Preoperative MPV/PC in peripheral blood of patients with CRC was lower than the control group. Meanwhile, the combined detection of tumor markers with MPV/PC can improve the diagnostic value of CRC, r...

Relationship between platelet count and severity of neonatal respiratory distress syndrome.

Neonatal respiratory distress syndrome (NRDS) is a primary cause of morbidity and mortality in premature infants. Platelets have a unique role in lung repair and remodeling. This study aimed to determ... The study included 234 newborns diagnosed with NRDS from January 2019 to August 2023. This study employed two methods of grouping: the first based on platelet count, dividing participants into thrombo... A higher proportion of newborns in the severe group exhibited thrombocytopenia (severe group = 41.7%, mild-moderate group = 19.0%). Hospital stay, ventilation time, oxygen therapy duration were longer... NRDS accompanied by thrombocytopenia indicates a more severe condition and poorer clinical outcomes. It is hypothesized that NRDS with thrombocytopenia involves a complex multifactorial etiology, incl...

The Use of Platelet Count and Indices as Prognostic Factors for Mortality in Children with Sepsis.

Sepsis is still one of the leading causes of mortality and morbidity in children worldwide. Consumptive coagulopathy and suppression of thrombopoiesis in the bone marrow resulting from immune dysregul... This is a cross-sectional study of 45 children diagnosed with sepsis on admission at Haji Adam Malik Hospital, Medan, North Sumatra, Indonesia, between October and November 2022. Blood samples were dr... MPV, PDW, and PDW/PLT were significantly higher in non-survivors than survivors (P=0.04, P=0.02, and P=0.04, respectively). ROC curve analysis showed that PDW had the largest AUC (0.708 [95% CI=0.549-... Admission PDW is a fast and specific tool to predict the outcome of children with sepsis....

Gut microbiota were altered with platelet count and red blood cell count in immune thrombocytopenia patients with different treatments.

The gut microbiome is clearly linked to the development of various autoimmune diseases, however, its association with immune thrombocytopenia (ITP) is less well understood. The current study collected...